Notice: This company has been marked as potentially delisted and may not be actively trading. Medicines (MDCO) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period 3D Medicines Inc. Reports 2024 Financial Results Amid Market ChallengesMarch 31 at 11:34 AM | tipranks.com3D Medicines Inc. Forms Nomination Committee for Enhanced GovernanceMarch 31 at 11:34 AM | tipranks.com3D Medicines Announces Board Composition and Governance StructureMarch 31 at 11:34 AM | tipranks.comIs Blueprint Medicines (BPMC) One of the Best Mid Cap Biotech Stocks to Buy?March 30 at 5:32 PM | insidermonkey.comIs Revolution Medicines (RVMD) the Best Mid Cap Biotech Stock to Buy?March 30 at 5:32 PM | insidermonkey.comEuropean committee says Lilly Alzheimer’s drug shouldn’t get marketing approvalMarch 28 at 10:53 AM | financialpost.comEuropean committee says Lilly Alzheimer's drug shouldn't get marketing approvalA European regulatory committee has rejected Eli Lilly’s U.S.-approved Alzheimer’s disease treatment over potentially dangerous risks of brain bleeding and swellingMarch 28 at 10:32 AM | marketbeat.comEuropean Medicines Agency (EMA) Validates Henlius and Organon Filing for Perjeta® (pertuzumab) Biosimilar Candidate HLX11March 28 at 6:28 AM | financialpost.comTYK Medicines Reports 2024 Annual Results and Corporate ChangesMarch 27, 2025 | tipranks.comFull Year 2024 Everest Medicines Ltd Earnings Call TranscriptMarch 27, 2025 | gurufocus.comEverest Medicines Ltd (FRA:6HN) (Full Year 2024) Earnings Call Highlights: Record Revenue ...March 27, 2025 | gurufocus.comUK Medicines and Healthcare Products Regulatory Agency Confirms Acceptance of Marketing Authorization Application for Proposed Biosimilar to Xolair ® (omalizumab)March 26, 2025 | investing.comEverest Medicines Announces Financial Results for Full Year Ended December 31, 2024March 25, 2025 | investing.comIs Blueprint Medicines Corporation (BPMC) a Promising Biotech Stock According to Wall Street AnalystsMarch 25, 2025 | insidermonkey.comEverest Medicines Ltd. Releases 2024 Annual ResultsMarch 25, 2025 | tipranks.comGSK’s Nucala Application for COPD Accepted by EMAMarch 24, 2025 | tipranks.comEverest Medicines Announces FDA Clearance of IND Application for Tumor-Associated Antigen Vaccine EVM14March 23, 2025 | investing.com3D Medicines Inc. Schedules Board Meeting for Financial ReviewMarch 19, 2025 | tipranks.comDirector’s Major Stock Sale Shakes Up Blueprint Medicines!March 17, 2025 | tipranks.comGilead Sciences - Leader In HIV MedicinesMarch 14, 2025 | talkmarkets.com3D Medicines Inc. Advances ‘AI + mRNA’ Cancer Vaccine Strategy with New Patent FilingMarch 11, 2025 | tipranks.comTYK Medicines Reports Positive Phase II Trial Results for TY-9591March 9, 2025 | tipranks.comPraxis Precision Medicines Updates on Programs and FinancesMarch 5, 2025 | tipranks.comBlueprint Medicines: Hold Rating Amid Concerns Over Ayvakit’s Liver Function Test ElevationsMarch 4, 2025 | tipranks.comHHLR ADVISORS, LTD. Acquires Significant Stake in BeOne Medicines LtdMarch 4, 2025 | gurufocus.comBaker Bros. Advisors LP Reduces Stake in BeOne Medicines LtdMarch 1, 2025 | gurufocus.comPositive Outlook on Praxis Precision Medicines Amidst Phase 3 ET Program ChallengesFebruary 28, 2025 | tipranks.comPraxis Precision Medicines: Navigating Challenges and Catalysts in Epilepsy TreatmentFebruary 28, 2025 | tipranks.comEverest Medicines to Hold Investor Calls with Updates on mRNA Therapeutic Vaccine ProgramsFebruary 28, 2025 | investing.comDecoding Revolution Medicines Inc (RVMD): A Strategic SWOT InsightFebruary 28, 2025 | gurufocus.comRevolution Medicines’ Earnings Call: Positive Progress Amid Rising CostsFebruary 27, 2025 | tipranks.comRevolution Medicines Inc (RVMD) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...February 27, 2025 | gurufocus.comQ4 2024 Revolution Medicines Inc Earnings Call TranscriptFebruary 27, 2025 | gurufocus.comRevolution Medicines Inc (RVMD) Announces Financial Results and Clinical ProgressFebruary 26, 2025 | gurufocus.comAstraZeneca's Investigational Cancer Drug Shows First-Line Benefit In Combination With Widely Cancer MedicinesFebruary 26, 2025 | benzinga.comEarnings To Watch: Revolution Medicines Inc (RVMD) Reports Q4 2024 ResultFebruary 25, 2025 | gurufocus.comRevolution Medicines Inc (RVMD) Announces Participation in Upcoming Investor ConferencesFebruary 25, 2025 | gurufocus.comEverest Medicines to Review Annual Results on March 25, 2025February 25, 2025 | tipranks.comMesoblast Ltd (MESO) Appoints Dr. Gregory George to Board of DirectorsFebruary 24, 2025 | gurufocus.comBlueprint Medicines Corporation (BPMC): Among the Oversold Biotech Stocks to Buy NowFebruary 24, 2025 | insidermonkey.comEuropean Medicines Agency Validates Gilead's Marketing Authorization Application and ...February 24, 2025 | gurufocus.comRevolution Medicines Inc (RVMD) Announces Upcoming Financial Results ReleaseFebruary 20, 2025 | gurufocus.comRevolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2024 After Market Close on February 26, 2025February 19, 2025 | investing.comTYK Medicines Completes H Share Full CirculationFebruary 18, 2025 | tipranks.com3D Medicines Inc. Reports Resolution in Civil Proceedings, Ensures Continued OperationsFebruary 17, 2025 | tipranks.comCautious Optimism: Hold Rating Given to Blueprint Medicines Amid Financial Performance Concerns and Slower Ayvakit Growth ProjectionsFebruary 17, 2025 | tipranks.comSteven Cohen's Strategic Acquisition in Praxis Precision Medicines IncFebruary 15, 2025 | gurufocus.comCormorant Asset Management's Strategic Acquisition of Praxis Precision Medicines SharesFebruary 14, 2025 | gurufocus.comBlueprint Medicines Corporation (NASDAQ:BPMC) Q4 2024 Earnings Call TranscriptFebruary 14, 2025 | insidermonkey.comOptimistic Growth Potential and Market Expansion Justify Buy Recommendation for Blueprint MedicinesFebruary 13, 2025 | tipranks.com Remove Ads Get Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for MDCO and its competitors with MarketBeat's FREE daily newsletter. Email Address MDCO Media Mentions By Week MDCO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDCO News Sentiment▼0.000.82▲Average Medical News Sentiment MDCO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDCO Articles This Week▼152▲MDCO Articles Average Week Remove Ads Get Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for MDCO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RPRX News Today JAZZ News Today CORT News Today PRGO News Today SUPN News Today PCRX News Today OMER News Today NKTR News Today ASMB News Today CPIX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MDCO) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Medicines Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
